Chemours
371 hedge funds and large institutions have $1.16B invested in Chemours in 2016 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 84 increasing their positions, 144 reducing their positions, and 83 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
36% more capital invested
Capital invested by funds: $858M → $1.16B (+$306M)
9.71% more ownership
Funds ownership: 68.15% → 77.86% (+9.7%)
11% less funds holding
Funds holding: 415 → 371 (-44)
20% less call options, than puts
Call options by funds: $8.76M | Put options by funds: $10.9M
42% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 144
51% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 83
Top Buyers
| 1 |
GC
Greenlight Capital
New York
|
+$67.4M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$35.7M |
| 3 |
GCM
Gates Capital Management
New York
|
+$19.6M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$15.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.6M |
Top Sellers
CC Hedge Fund Activity: Q2 2016 in Review
371 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q2 2016, worth a combined $1.16B — up 36% from $858M a quarter earlier.
Sellers outnumbered buyers: 83 funds closed out of CC and 41 opened new positions — a net loss of 42 holders — while 144 trimmed existing stakes and 84 added.
The largest buyer was Greenlight Capital, adding an estimated $67.4M. The largest seller was Conatus Capital Management, exiting entirely with an estimated $32.8M sold.
- 371 institutional investors held Chemours (CC) as of Q2 2016, down from 415 in Q1 2016.
- Funds reported $1.16B of Chemours stock for Q2 2016, up 36% quarter-over-quarter.
- 41 funds opened new Chemours positions in Q2 2016 and 83 closed out, a net change of -42 holders.
- The largest Chemours buyer in Q2 2016 was Greenlight Capital, an estimated $67.4M added.
- The largest Chemours seller in Q2 2016 was Conatus Capital Management, an estimated $32.8M sold.
Based on aggregated 13F filings for Q2 2016.